Suppr超能文献

2-甲氧基雌二醇的潜在血管作用。

Potential vascular actions of 2-methoxyestradiol.

作者信息

Dubey Raghvendra K, Jackson Edwin K

机构信息

Clinic for Reproductive Endocrinology, Department of Obstetrics and Gynecology, Zurich Center for Integrative Human Physiology, University Hospital Zurich, Frauenklinikstrasse, Zurich, Switzerland.

出版信息

Trends Endocrinol Metab. 2009 Oct;20(8):374-9. doi: 10.1016/j.tem.2009.04.007. Epub 2009 Sep 4.

Abstract

2-Methoxyestradiol (2-ME) is a biologically active metabolite of 17beta-estradiol that appears to inhibit key processes associated with cell replication in vitro. The molecule has been suggested to have potent growth-inhibitory effects on proliferating cells, including smooth muscle cells and endothelial cells, and may be antiangiogenic. Because of these potential roles for 2-ME, its lack of cytotoxicity and low estrogenic activity, we hypothesize that 2-ME could be a valuable therapeutic molecule for prevention and treatment of cardiovascular diseases. Whether 2-ME is as effective in vivo as it is in vitro at modulating vascular processes remains controversial. Here we discuss recent developments regarding mechanisms by which 2-ME might regulate vascular activity and angiogenesis and speculate on the therapeutic implications of these developments.

摘要

2-甲氧基雌二醇(2-ME)是17β-雌二醇的一种生物活性代谢产物,在体外似乎能抑制与细胞复制相关的关键过程。该分子已被认为对增殖细胞,包括平滑肌细胞和内皮细胞具有强大的生长抑制作用,并且可能具有抗血管生成作用。鉴于2-ME的这些潜在作用、其缺乏细胞毒性以及低雌激素活性,我们推测2-ME可能是预防和治疗心血管疾病的一种有价值的治疗分子。2-ME在体内调节血管过程的效果是否与体外一样有效仍存在争议。在此,我们讨论关于2-ME可能调节血管活性和血管生成的机制的最新进展,并推测这些进展的治疗意义。

相似文献

1
Potential vascular actions of 2-methoxyestradiol.
Trends Endocrinol Metab. 2009 Oct;20(8):374-9. doi: 10.1016/j.tem.2009.04.007. Epub 2009 Sep 4.
2
Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.
Hypertension. 2010 Nov;56(5):964-72. doi: 10.1161/HYPERTENSIONAHA.110.152298. Epub 2010 Oct 4.
3
Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol.
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1935-42. doi: 10.1152/ajpheart.00723.2008. Epub 2008 Sep 5.
5
2-Methoxyestradiol: a potential treatment for multiple proliferative disorders.
Endocrinology. 2007 Sep;148(9):4125-7. doi: 10.1210/en.2007-0514.
6
2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
Mol Cancer Ther. 2006 Sep;5(9):2225-33. doi: 10.1158/1535-7163.MCT-06-0113.
8
10
Increased 2-methoxyestradiol production in human coronary versus aortic vascular cells.
Hypertension. 2001 Feb;37(2 Pt 2):658-62. doi: 10.1161/01.hyp.37.2.658.

引用本文的文献

2
Estradiol Downregulates MicroRNA-193a to Mediate Its Angiogenic Actions.
Cells. 2025 Jul 23;14(15):1134. doi: 10.3390/cells14151134.
5
Nobiletin: a potential erythropoietin receptor activator protects renal cells against hypoxia.
Apoptosis. 2025 Apr;30(3-4):842-860. doi: 10.1007/s10495-024-02067-9. Epub 2025 Jan 4.
10
Trajectories of Blood Pressure in Midlife Women: Does Menopause Matter?
Circ Res. 2022 Feb 4;130(3):312-322. doi: 10.1161/CIRCRESAHA.121.319424. Epub 2022 Jan 6.

本文引用的文献

1
Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol.
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1935-42. doi: 10.1152/ajpheart.00723.2008. Epub 2008 Sep 5.
2
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia.
Nature. 2008 Jun 19;453(7198):1117-21. doi: 10.1038/nature06951. Epub 2008 May 11.
3
Medroxyprogesterone abrogates the inhibitory effects of estradiol on vascular smooth muscle cells by preventing estradiol metabolism.
Hypertension. 2008 Apr;51(4):1197-202. doi: 10.1161/HYPERTENSIONAHA.107.106575. Epub 2008 Feb 7.
4
2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.
Am J Pathol. 2008 Feb;172(2):534-44. doi: 10.2353/ajpath.2008.061244. Epub 2008 Jan 17.
5
2-Methoxyestradiol reduces monocyte adhesion to aortic endothelial cells in ovariectomized rats.
Endocr J. 2007 Dec;54(6):1027-31. doi: 10.1507/endocrj.k07e-034. Epub 2007 Sep 8.
6
2-Methoxyestradiol: a potential treatment for multiple proliferative disorders.
Endocrinology. 2007 Sep;148(9):4125-7. doi: 10.1210/en.2007-0514.
10
2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Vascul Pharmacol. 2006 Dec;45(6):358-67. doi: 10.1016/j.vph.2006.05.007. Epub 2006 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验